Cargando…

CD44 is a determinant of inflammatory bone loss

Chronic inflammation is a major trigger of local and systemic bone loss. Disintegration of cell–matrix interaction is a prerequisite for the invasion of inflammatory tissue into bone. CD44 is a type I transmembrane glycoprotein that connects a variety of extracellular matrix proteins to the cell sur...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hayer, Silvia, Steiner, Günter, Görtz, Birgit, Reiter, Erika, Tohidast-Akrad, Makiyeh, Amling, Michael, Hoffmann, Oskar, Redlich, Kurt, Zwerina, Jochen, Skriner, Karl, Hilberg, Frank, Wagner, Erwin F., Smolen, Josef S., Schett, Georg
Formato:	Texto
Lenguaje:	English
Publicado:	The Rockefeller University Press 2005
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2213110/ https://www.ncbi.nlm.nih.gov/pubmed/15781582 http://dx.doi.org/10.1084/jem.20040852

Ejemplares similares

The stressed synovium
por: Schett, Georg, et al.
Publicado: (2001)

Arthritis induces lymphocytic bone marrow inflammation and endosteal bone formation
por: Görtz, B, et al.
Publicado: (2004)

CD44 regulates bone erosion and osteoclastogenesis in arthritis
por: Hayer, S, et al.
Publicado: (2004)

Aberrant expression of the autoantigen hnRNP-A2/RA33 in the joints of patients with rheumatoid arthritis and TNF-alpha transgenic mice: a clue to autoimmunity?
por: Hayer, S, et al.
Publicado: (2001)

Osteoclasts are essential for TNF-mediated joint destruction
por: Redlich, KR, et al.
Publicado: (2002)

Tumour necrosis factor activates the mitogen-activated protein kinases p38α and ERK in the synovial membrane in vivo
por: Görtz, Birgit, et al.
Publicado: (2005)

Identification of hnRNP-A2 (RA33) as a major B-cell and T-cell autoantigen in pristane–induced arthritis
por: Hoffmann, MH, et al.
Publicado: (2005)

Therapeutic targeting of osteoclasts by osteoprotegerin and bisphosphonates leads to a reduction of TNFalpha-mediated bone resorption
por: Redlich, K, et al.
Publicado: (2001)

Overexpression of the autoantigen hnRNP-A2 (RA33), the tumour suppressor p53 and activated MAP-Kinase p38 in inflamed synovial tissue
por: Hayer, S, et al.
Publicado: (2002)

Adenoviral-based overexpression of TIMP-1 reduces tissue damage in the joints TNF-transgenic mice
por: Schett, G, et al.
Publicado: (2001)

Overexpression of TNF causes bilateral sacroiliitis
por: Redlich, K, et al.
Publicado: (2004)

Imbalance of local bone metabolism in inflammatory arthritis and its reversal upon tumor necrosis factor blockade: direct analysis of bone turnover in murine arthritis
por: Zwerina, Jochen, et al.
Publicado: (2006)

Effect of osteoprotegerin and pamidronate treatment in transgenic mice overexpressing human TNF
por: Redlich, K, et al.
Publicado: (2001)

Repair of local bone erosions and reversal of systemic bone loss upon therapy with anti-TNF in combination with OPG or PTH in TNF-mediated arthritis
por: Redlich, K, et al.
Publicado: (2004)

CD44 regulates bone erosion and osteoclastogenesis in arthritis
por: Schett, G, et al.
Publicado: (2003)

Osteoprotegerin protects from generalized bone loss in TNF-transgenic mice
por: Hayer, S, et al.
Publicado: (2003)

Heme oxygenase 1 regulates osteoclastogenesis
por: Zwerina, J, et al.
Publicado: (2005)

Adenoviral-based overexpression of TIMP-1 reduces tissue damage in the joints of TNF-alpha transgenic mice
por: Schett, G, et al.
Publicado: (2001)

JNK1 is not essential for TNF-mediated joint disease
por: Köller, Marcus, et al.
Publicado: (2005)

Autoantibodies to hnRNP-A2 in SLE: identification of disease-specific linear epitopes and correlation with disease activity and clinical features
por: Schett, G, et al.
Publicado: (2003)

Isolated and combined inhibition of TNF-, IL-1 and RANKL-pathways in TNF-induced arthritis: effects on synovial inflammation, bone erosion and cartilage destruction
por: Zwerina, J, et al.
Publicado: (2003)

Zoledronic acid protects from local and systemic bone loss in tumor necrosis factor-mediated arthritis
por: Redlich, K, et al.
Publicado: (2004)

Zoledronic acid protects from local and systemic bone loss in TNF-mediated arthritis
por: Zwerina, J, et al.
Publicado: (2004)

The role of osteoprotegerin in arthritis
por: Schett, Georg, et al.
Publicado: (2003)

Fra-1 regulates inflammatory and degenerative arthritis
por: Kireva, T, et al.
Publicado: (2010)

Direct analysis of bone turnover in experimental arthritis
por: Polzer, K, et al.
Publicado: (2005)

The spliceosomal autoantigen heterogeneous nuclear ribonucleoprotein A2 (hnRNP-A2) is a major T cell autoantigen in patients with systemic lupus erythematosus
por: Fritsch-Stork, Ruth, et al.
Publicado: (2006)

The need for prognosticators in rheumatoid arthritis. Biological and clinical markers: where are we now?
por: Smolen, Josef S, et al.
Publicado: (2008)

Analysis of combined deficiency of interleukin-1 and -6 versus single deficiencies in TNF-mediated arthritis and systemic bone loss
por: Hayer, Silvia, et al.
Publicado: (2022)

Cartilage damage and bone erosion are more prominent determinants of functional impairment in longstanding experimental arthritis than synovial inflammation
por: Hayer, Silvia, et al.
Publicado: (2016)

Characterization of the T cell response to hnRNP-A2 (RA33) in HLA-DR4 transgenic mice
por: Hoffmann, M, et al.
Publicado: (2004)

Gait changes precede overt arthritis and strongly correlate with symptoms and histopathological events in pristane-induced arthritis
por: Hoffmann, Markus H, et al.
Publicado: (2010)

Tumor necrosis factor alpha downregulates bone morphogenetic protein expression and matrix macromolecule synthesis in articular cartilage
por: Bobacz, K, et al.
Publicado: (2004)

Autoantibodies in rheumatoid arthritis and their clinical significance
por: Steiner, Günter, et al.
Publicado: (2002)

Combined depletion of interleukin-1 and interleukin-6 does not exceed single depletion of interleukin -1 in TNF-mediated arthritis
por: Hayer, Silvia, et al.
Publicado: (2012)

Repair of local bone erosions by combined treatment with parathyroid hormone, osteoprotegerin and anti-tumor necrosis factor in tumor necrosis factor-transgenic mice
por: Redlich, K, et al.
Publicado: (2003)

Autoantibodies to the mRNA destabilizing protein hnRNP-D/AUF1 in patients with systemic autoimmune diseases
por: Skriner, K, et al.
Publicado: (2001)

Activator protein 1 (Fos/Jun) functions in inflammatory bone and skin disease
por: Zenz, Rainer, et al.
Publicado: (2008)

Nicotinic acetylcholine receptors modulate osteoclastogenesis
por: Mandl, Peter, et al.
Publicado: (2016)

Functional consultation and exercises improve grip strength in osteoarthritis of the hand – a randomised controlled trial
por: Stoffer-Marx, Michaela A., et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_pn5ctvujpdp15a4u1p5670alnb